Co-occurrence of injection drug use and hepatitis C increases epigenetic age acceleration that contributes to all-cause mortality among people living with HIV

Xiaoyu Lianga Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA;b VA Connecticut Healthcare System, West Haven, CT, USA;c Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USAView further author information

Amy C. Justiceb VA Connecticut Healthcare System, West Haven, CT, USA;d New Haven Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, New Haven, CT, USAView further author information

Vincent C. Marconie Emory University School of Medicine and Rollins School of Public Health; the Atlanta Veterans Affairs Medical Center, Atlanta, GeorgiaView further author information

Bradley E. Aouizeratf Bluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, USA;g Department of Oral and Maxillofacial Surgery, College of Dentistry, New York University, New York, NY, USAView further author information

Ke Xua Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA;b VA Connecticut Healthcare System, West Haven, CT, USACorrespondence[email protected]
View further author information

Co-occurrence of injection drug use and hepatitis C increases epigenetic age acceleration that contributes to all-cause mortality among people living with HIV

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Co-occurrence of injection drug use and hepatitis C increases epigenetic age acceleration that contributes to all-cause mortality among people living with HIV

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date